Next Article in Journal
Exploratory Analyses of Circulating Neoplastic-Immune Hybrid Cells as Prognostic Biomarkers in Advanced Intrahepatic Cholangiocarcinoma
Previous Article in Journal
Toxicological and Pharmacological Activities, and Potential Medical Applications, of Marine Algal Toxins
Previous Article in Special Issue
Nucleic Acids-Based Biomarkers for Alzheimer’s Disease Diagnosis and Novel Molecules to Treat the Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

The Role of α-Synuclein in Etiology of Neurodegenerative Diseases

1
Department of Neurodegeneration Diagnostics, Medical University of Białystok, 15-089 Białystok, Poland
2
Department of Biochemical Diagnostics, University Hospital in Białystok, 15-269 Białystok, Poland
3
Dementia Disorders Centre, Medical University of Wroclaw, 50-425 Ścinawa, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(17), 9197; https://doi.org/10.3390/ijms25179197 (registering DOI)
Submission received: 6 August 2024 / Revised: 22 August 2024 / Accepted: 23 August 2024 / Published: 24 August 2024

Abstract

A presynaptic protein called α-synuclein plays a crucial role in synaptic function and neurotransmitter release. However, its misfolding and aggregation have been implicated in a variety of neurodegenerative diseases, particularly Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Emerging evidence suggests that α-synuclein interacts with various cellular pathways, including mitochondrial dysfunction, oxidative stress, and neuroinflammation, which contributes to neuronal cell death. Moreover, α-synuclein has been involved in the propagation of neurodegenerative processes through prion-like mechanisms, where misfolded proteins induce similar conformational changes in neighboring neurons. Understanding the multifaced roles of α-synuclein in neurodegeneration not only aids in acquiring more knowledge about the pathophysiology of these diseases but also highlights potential biomarkers and therapeutic targets for intervention in alpha-synucleinopathies. In this review, we provide a summary of the mechanisms by which α-synuclein contributes to neurodegenerative processes, focusing on its misfolding, oligomerization, and the formation of insoluble fibrils that form characteristic Lewy bodies. Furthermore, we compare the potential value of α-synuclein species in diagnosing and differentiating selected neurodegenerative diseases.
Keywords: α-synuclein; neurodegeneration; Parkinson’s disease; dementia with Lewy bodies; multiple system atrophy; synucleinopathies α-synuclein; neurodegeneration; Parkinson’s disease; dementia with Lewy bodies; multiple system atrophy; synucleinopathies

Share and Cite

MDPI and ACS Style

Krawczuk, D.; Groblewska, M.; Mroczko, J.; Winkel, I.; Mroczko, B. The Role of α-Synuclein in Etiology of Neurodegenerative Diseases. Int. J. Mol. Sci. 2024, 25, 9197. https://doi.org/10.3390/ijms25179197

AMA Style

Krawczuk D, Groblewska M, Mroczko J, Winkel I, Mroczko B. The Role of α-Synuclein in Etiology of Neurodegenerative Diseases. International Journal of Molecular Sciences. 2024; 25(17):9197. https://doi.org/10.3390/ijms25179197

Chicago/Turabian Style

Krawczuk, Daria, Magdalena Groblewska, Jan Mroczko, Izabela Winkel, and Barbara Mroczko. 2024. "The Role of α-Synuclein in Etiology of Neurodegenerative Diseases" International Journal of Molecular Sciences 25, no. 17: 9197. https://doi.org/10.3390/ijms25179197

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop